A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology
Posted: Friday, March 31, 2023
News
Exploring Precision Oncology - Interview with Dr. Razelle Kurzrock, Chief Medical Officer and Dr. Sewanti Limaye at WIN 2022 Symposium
Posted: Friday, November 18, 2022
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung
Posted: Monday, November 07, 2022
Transcriptomics Plus ‘Immune Tolerance’ of Normal Tissue Shows Promise in Lung Cancer Prognosis
Posted: Tuesday, September 27, 2022
Survival-predicting algorithm passes first big test in patients with lung cancer
Posted: Tuesday, September 20, 2022
InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma
Posted: Monday, June 06, 2022
SPRING Phase I trial results published in Cancer Medicine, Wiley
Posted: Monday, March 28, 2022
JIPO and WIN Join Forces to Promote Immunotherapy and Precision Oncology in 2022
Posted: Monday, January 10, 2022
WIN SPRING 2021 Newsletter
Posted: Thursday, May 20, 2021
Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival
Posted: Friday, April 30, 2021
WIN’s Digital Display Precision Predictor biomarker to guide cancer targeted therapy
Posted: Friday, April 30, 2021